Genetic databases and governance

The Ethics and Governance of Human Genetic Databases: European Perspectives

Volumn , Issue , 2007, Pages 236-246

  Kattel, Rainer ^a  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862992298     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511611087.026     Document Type: Chapter

References (36)

1. Maren Hertweck, Christine Go¨beland and Ralf Baumeister, ‘C. Elegans SGK-1 is the Critical Component in the Akt/PKB Kinase Complex to Control Stress Response and Life Span’, Developmental Cell 6 (2004), pp. 577-588.
2. Daniel Callahan, False Hopes. Overcoming the Obstacles to a Sustainable, Affordable Medicine (New Brunswick, NJ: Rutgers University Press, 1999), p. 52.
3. Stephan Herrera, ‘Industrial Biotechnology - A Chance at Redemption’, Nature Biotechnology 22 (2004), pp. 671-675
4. Fox Keller, (2003) Making Sense of Life. Explaining Biological Development with Models, Metaphors, and Machines (Cambridge, MA: Harvard University Press), p. 2.
5. Francis Fukuyama, Our Posthuman Future. Consequences of the Biotechnology Revolution (New York: Farrar, Straus and Giroux, 2002);
6. Leon R. Kass, Life, Liberty and the Defense of Dignity. The Challenge for Bioethics (San Francisco: Encounter Books, 2002).
7. Brian Salter and Mavis Jones, ‘Regulating Human Genetics: The Changing Politic of Biotechnology Governance in the European Union’, Health, Risk and Society 4 (2002), pp. 325-339;
8. R. A. W. Rhodes, ‘The New Governance: Governing Without Government’, Political Studies 64 (1996), pp. 652-667.
9. Henry Mintzberg, ‘Managing Government - Governing Management’, Harvard Business Review 74 (1996), pp. 75-83;
10. B. Guy Peters and John Pierre, ‘Governance Without Government? Rethinking Public Administration’, Journal of Public Administration Research and Theory 8 (1998), pp. 223-244;
11. Klaus Ko¨nig, ‘Good Governance - As Steering and Value Concept for the Modern Administrative State’, in J. Corkery (ed.), Governance: Concepts and Applications (Brussels: International Institute of Administrative Sciences, 1999), pp. 67-93;
12. Keith Griffin, ‘Economic Globalization and Institutions of Global Governance’, Development and Change 34 (2003), pp. 789-807;
13. seeWolfgang Drechsler, ‘Governance, Good Governance, and Government: The Case for Estonian Administrative Capacity’, Trames 8 (2004), pp. 388-396.
14. Allen Schick, ‘The Performing State: Reflection on an Idea Whose Time Has Come but Whose Implementation Has Not’, OECD Journal on Budgeting 3 (2003), pp. 71-103.
15. Ezra Suleiman, (2003) Dismantling Democratic States (Princeton: Princeton University Press).
16. Francis Fukuyama, State Building. Governance and World Order in the Twenty-First Century (London: Profile Books, 2004), pp. 9-25.
17. Francis Fukuyama and Caroline S. Wagner (2000), Information and Biological Revolutions: Global Governance Challenges, Summary of a Study Group (RAND MR-1139-DARPA);
18. Melissa A. Austin, Sarah Harding and Courtney McElroy, ‘Genebanks: A Comparison of Eight Proposed International Genetic Databases’, Community Genetics 6 (2003), pp. 37-45
19. Paul Martin, ‘Genetic Governance: The Risks, Oversight and Regulation of Genetic Databases in the UK’, New Genetics and Society 20 (2001), pp. 157-183
20. Hans-E. Hagen and Jan Carlstedt-Duke, ‘Building Global Networks for Human Diseases: Genes and Populations’, Nature Medicine 10 (2004), pp. 665-667
21. Ernst-Wolfgang Bockenforde, ‘Die Bedeutung der Unterscheidung von Staat und Gesellschaft im demokratischen Sozialstaat der Gegenwart’, in E.-W. Bockenforde, Recht, Staat, Freiheit (Frankfurt am Main: Suhrkamp, 1991), pp. 209-243
22. Richard Tutton, Jane Kaye and Klaus Hoyer, ‘Governing UK Biobank: The Importance of Ensuring Public Trust’, Trends in Biotechnology 22 (2004), pp. 284-285.
23. Ruth Chadwick and Ka˚re Berg, ‘Solidarity and Equity: New Ethical Framework for Genetic Databases’, Nature Review Genetics 2 (2001), pp. 318-321;
24. Jane Kaye, ‘Genetic Research on the UK Population - Do New Principles Need to be Developed?’, Trends in Molecular Medicine 7 (2001), pp. 528-530;
25. Joseph A. Schumpeter, ‘The Economy as a Whole. Seventh Chapter of The Theory of Economic Development’, Industry and Innovation 1/2 (2002), pp. 93-145.
26. Rainer Kattel and Riivo Anton, ‘Estonian Genome Foundation and Economic Development’, Trames 8 (2004), pp. 106-128
27. Hilary Rose, ‘An Ethical Dilemma. The Rise and Fall of UmanGenomics - The Model Biotech Company?’, Nature 425 (2003), pp. 123-124;
28. Klaus Hoeyer, “‘Science is Really Needed - That’s All I Know”: Informed Consent and the Non-Verbal Practices of Collecting Blood for Genetic Research in Northern Sweden’, New Genetics and Society 22 (2003), pp. 229-244.
29. Jon F. Merz, Glenn E. Mcgee and Pamela Sanker, “‘Iceland Inc.”? On the Ethicsof Commercial Population Genomics’, Social Science and Medicine 58 (2004), pp. 1201-1209.
30. Richard Horton, (2004) ‘The Dawn of McScience’, New York Review of Books 51, 11 March;
31. Marcia Angell, (2004) ‘The Truth About the Drug Companies’, New York Review of Books 51, 15 July.
32. Mark Harvey and Andrew McMeekin, ‘Public-Private Collaborations and the Race to Sequence Agrobacterium Tumefaciens’, Nature Biotechnology 22 (2004), pp. 807-810.
33. Martin Lindner, (2004) ‘Im Supermarkt der Biotechnik. Eine Reportage’, Gegenworte. Hefte fu¨r den Disput u¨ ber Wissen 13, pp. 30-35.
34. Joseph A. Schumpeter, Historical and Statistical Analysis of the Capitalist Process (Philadelphia: Porcupine Press, 1939), pp. 58-61.
35. Henry Etzkowitz, ‘The Evolution of the Entrepreneurial University’, International Journal of Technology and Globalisation 1 (2004), pp. 64-77
36. Anne Tomes, ‘UK Government Science Policy: The “Enterprise Deficit” Fallacy’, Technovation 23 (2003), pp. 785-792